vs

Side-by-side financial comparison of CME Group (CME) and Visa Inc. (V). Click either name above to swap in a different company.

Visa Inc. is the larger business by last-quarter revenue ($10.9B vs $1.9B, roughly 5.8× CME Group). Visa Inc. runs the higher net margin — 53.7% vs 0.1%, a 53.6% gap on every dollar of revenue. On growth, Visa Inc. posted the faster year-over-year revenue change (14.6% vs 14.5%). Over the past eight quarters, Visa Inc.'s revenue compounded faster (11.5% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Visa Inc. is an American multinational payment card services corporation headquartered in San Francisco, California. It facilitates electronic funds transfers throughout the world, most commonly through Visa-branded credit cards, debit cards and prepaid cards.

CME vs V — Head-to-Head

Bigger by revenue
V
V
5.8× larger
V
$10.9B
$1.9B
CME
Growing faster (revenue YoY)
V
V
+0.1% gap
V
14.6%
14.5%
CME
Higher net margin
V
V
53.6% more per $
V
53.7%
0.1%
CME
Faster 2-yr revenue CAGR
V
V
Annualised
V
11.5%
10.8%
CME

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
V
V
Revenue
$1.9B
$10.9B
Net Profit
$1.2M
$5.9B
Gross Margin
Operating Margin
0.1%
61.8%
Net Margin
0.1%
53.7%
Revenue YoY
14.5%
14.6%
Net Profit YoY
20.7%
14.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
V
V
Q1 26
$1.9B
Q4 25
$1.6B
$10.9B
Q3 25
$1.5B
$10.7B
Q2 25
$1.7B
$10.2B
Q1 25
$1.6B
$9.6B
Q4 24
$1.5B
$9.5B
Q3 24
$1.6B
$9.6B
Q2 24
$1.5B
$8.9B
Net Profit
CME
CME
V
V
Q1 26
$1.2M
Q4 25
$1.2B
$5.9B
Q3 25
$908.0M
$5.1B
Q2 25
$1.0B
$5.3B
Q1 25
$956.2M
$4.6B
Q4 24
$874.6M
$5.1B
Q3 24
$912.8M
$5.3B
Q2 24
$883.2M
$4.9B
Operating Margin
CME
CME
V
V
Q1 26
0.1%
Q4 25
61.8%
61.8%
Q3 25
63.3%
57.3%
Q2 25
66.7%
60.7%
Q1 25
67.5%
56.6%
Q4 24
62.1%
65.6%
Q3 24
64.6%
66.0%
Q2 24
65.3%
66.7%
Net Margin
CME
CME
V
V
Q1 26
0.1%
Q4 25
71.7%
53.7%
Q3 25
59.1%
47.5%
Q2 25
60.6%
51.8%
Q1 25
58.2%
47.7%
Q4 24
57.3%
53.8%
Q3 24
57.6%
55.3%
Q2 24
57.6%
54.7%
EPS (diluted)
CME
CME
V
V
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
V
V
Cash + ST InvestmentsLiquidity on hand
$2.4B
$14.8B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$38.8B
Total Assets
$202.0B
$96.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
V
V
Q1 26
$2.4B
Q4 25
$4.5B
$14.8B
Q3 25
$2.6B
$17.2B
Q2 25
$2.1B
$17.1B
Q1 25
$1.5B
$11.7B
Q4 24
$3.0B
$12.4B
Q3 24
$2.4B
$12.0B
Q2 24
$1.9B
$12.9B
Total Debt
CME
CME
V
V
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
V
V
Q1 26
Q4 25
$28.7B
$38.8B
Q3 25
$28.2B
$37.9B
Q2 25
$27.7B
$38.7B
Q1 25
$27.0B
$38.0B
Q4 24
$26.5B
$38.3B
Q3 24
$28.2B
$39.1B
Q2 24
$27.6B
$39.7B
Total Assets
CME
CME
V
V
Q1 26
$202.0B
Q4 25
$198.4B
$96.8B
Q3 25
$187.1B
$99.6B
Q2 25
$179.9B
$100.0B
Q1 25
$157.8B
$92.9B
Q4 24
$137.4B
$91.9B
Q3 24
$137.8B
$94.5B
Q2 24
$123.4B
$91.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
V
V
Operating Cash FlowLast quarter
$6.8B
Free Cash FlowOCF − Capex
$6.4B
FCF MarginFCF / Revenue
58.7%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$22.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
V
V
Q1 26
Q4 25
$1.1B
$6.8B
Q3 25
$968.1M
$6.2B
Q2 25
$1.1B
$6.7B
Q1 25
$1.1B
$4.7B
Q4 24
$1.0B
$5.4B
Q3 24
$1.0B
$6.7B
Q2 24
$776.9M
$5.1B
Free Cash Flow
CME
CME
V
V
Q1 26
Q4 25
$1.1B
$6.4B
Q3 25
$949.7M
$5.8B
Q2 25
$1.0B
$6.3B
Q1 25
$1.1B
$4.4B
Q4 24
$991.7M
$5.1B
Q3 24
$973.2M
$6.4B
Q2 24
$758.7M
$4.7B
FCF Margin
CME
CME
V
V
Q1 26
Q4 25
66.8%
58.7%
Q3 25
61.8%
54.5%
Q2 25
61.5%
62.0%
Q1 25
67.1%
45.5%
Q4 24
65.0%
53.1%
Q3 24
61.4%
66.1%
Q2 24
49.5%
53.2%
Capex Intensity
CME
CME
V
V
Q1 26
Q4 25
2.0%
3.5%
Q3 25
1.2%
3.6%
Q2 25
1.1%
4.1%
Q1 25
0.9%
3.4%
Q4 24
1.7%
3.6%
Q3 24
1.9%
3.2%
Q2 24
1.2%
4.5%
Cash Conversion
CME
CME
V
V
Q1 26
Q4 25
0.96×
1.16×
Q3 25
1.07×
1.23×
Q2 25
1.03×
1.28×
Q1 25
1.17×
1.03×
Q4 24
1.16×
1.05×
Q3 24
1.10×
1.25×
Q2 24
0.88×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

V
V

Data Processing Revenues$5.5B51%
International Transaction Revenues$3.7B34%
Service Other$1.2B11%
Other$491.0M5%

Related Comparisons